Although TP53 mutations are present in approximately 96% of high-grade serous ovarian cancer cases, no mutations were detected in the hotspot regions of exons 3–8 within the OVAR79 cells [7]. This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.